This article is authored by Dr. GSK Velu, healthtech entrepreneur and CMD, Maxivision, Neuberg and Trivitron.
Multi-phase initiative will generate single cell and spatial data from over 20,000 samples across leading immuno-oncology laboratories to map the immune landscape of cancer and drive the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results